Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03874052
Brief Title: Ruxolitinib and Venetoclax in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

First Submitted : January 10, 2019
First Submitted that Met QC Criteria : March 11, 2019
First Posted : March 14, 2019

Last Update Submitted that Met QC Criteria : October 28, 2019
Last Update Posted : October 30, 2019